Vineet Laboratories Stock Screener | Share Price & Fundamental Analysis
VINEETLAB
Pharmaceuticals
Screen Vineet Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹35.31
▲
0.90 (2.62%)
Share Price BSE
₹34.94
▲
0.48 (1.39%)
Market Cap
₹75.17 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.72
EPS (TTM)
₹-21.90
Dividend Yield
-
Debt to Equity
1.71
52W High
₹47.87
52W Low
₹34.41
Operating Margin
-20.00%
Profit Margin
-28.81%
Revenue (TTM)
₹59.00
EBITDA
₹-10.00
Net Income
₹-17.00
Total Assets
₹95.00
Total Equity
₹15.00
Vineet Laboratories Share Price History - Stock Screener Chart
Screen VINEETLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Vineet Laboratories Company Profile - Fundamental Screener
Screen Vineet Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VINEETLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE505Y01010
Vineet Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen VINEETLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 95 | 117 | 116 | 133 | 109 | 0 | 0 |
| Current Assets | 67 | 88 | 88 | 103 | 86 | 0 | 0 |
| Fixed Assets | 26 | 27 | 27 | 21 | 20 | 0 | 0 |
| Liabilities | |||||||
| Total Liabilities | 95 | 117 | 116 | 133 | 109 | 0 | 0 |
| Current Liabilities | 6 | 6 | 8 | 5 | 8 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 15 | 35 | 34 | 33 | 27 | 0 | 0 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 0 | 0 |
| Reserves & Surplus | 5 | 26 | 25 | 24 | 17 | 0 | 0 |
Screen VINEETLAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 59 | 77 | 151 | 212 | 192 | 244 | 0 | 0 |
| Expenses | 69 | 91 | 143 | 205 | 178 | 235 | 0 | 0 |
| EBITDA | -10 | -14 | 8 | 8 | 13 | 9 | 0 | 0 |
| Operating Profit % | -20.00% | -22.00% | 5.00% | 4.00% | 7.00% | 3.00% | 0.00% | 0.00% |
| Depreciation | 3 | 3 | 3 | 2 | 2 | 2 | 0 | 0 |
| Interest | 5 | 4 | 5 | 3 | 2 | 3 | 0 | 0 |
| Profit Before Tax | -17 | -21 | 0 | 2 | 9 | 4 | 0 | 0 |
| Tax | 0 | -1 | -1 | 1 | 3 | 2 | 0 | 0 |
| Net Profit | -17 | -20 | 1 | 1 | 7 | 2 | 0 | 0 |
| EPS | -18.10 | -21.90 | 1.11 | 1.36 | 7.16 | 2.18 | -0.27 | 0.00 |
Vineet Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen VINEETLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 12 | -7 | -10 | 8 | 28 | 0 |
| Investing Activities | -3 | -2 | -7 | -4 | -8 | 0 |
| Financing Activities | -8 | 8 | 0 | 12 | 19 | 0 |
| Net Cash Flow | 0 | 0 | -16 | 16 | 38 | 0 |
Screen VINEETLAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.85% | 29.26% | 15.89% | 37.50% | 37.50% | 36.07% | 35.85% | 38.66% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 58.67% | 66.95% | 78.16% | 59.07% | 59.10% | 60.65% | 59.33% | 58.63% |
| Other Holding | 5.49% | 3.79% | 5.94% | 3.42% | 3.39% | 3.27% | 4.83% | 2.72% |
| Shareholder Count | 10,025 | 9,988 | 9,682 | 9,638 | 9,523 | 10,300 | 10,058 | 9,821 |
Vineet Laboratories Dividend Screener - Share Yield Analysis
Screen VINEETLAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.00 | 2.86% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Vineet Laboratories Index Membership - Market Screener Classification
Screen VINEETLAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Vineet Laboratories Market Events Screener - Corporate Actions
Screen VINEETLAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 9.41% | ||
| Annual General Meeting | NA | -0.33% | ||
| Annual General Meeting | NA | -3.45% | ||
| Dividend | ₹ 1.00 /share | 14.41% | ||
| 2025-12-23 | 2025-12-23 | Rights | 13:12 | 0.09% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -2.17% |
| 2025-10-23 | 2025-10-23 | Quarterly Result Announcement | NA | 2.46% |
| 2025-07-22 | 2025-07-22 | Quarterly Result Announcement | NA | -4.13% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -13.60% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.80% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 2.65% |
Vineet Laboratories Competitors Screener - Peer Comparison
Screen VINEETLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Vineet Laboratories Company Announcements - News Screener
Screen VINEETLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Announcement under Regulation 30 (LODR)-Raising of Funds | View |
| 2025-12-30 | Intimation Of International Securities Identification Number (ISIN) For The Rights Entitlements To Be Credited For The Purpose Of The Rights Issue | View |
| 2025-12-30 | Corporate Action-Intimation of Right issue | View |
| 2025-12-30 | The Record Date For The Proposed Rights Issue Is Tuesday December 23 2025. | View |
| 2025-12-30 | Announcement under Regulation 30 (LODR)-Raising of Funds | View |
| 2025-12-30 | Intimation Of Receipt Of In-Principle Approval From BSE And NSE For Rights Issue | View |
| 2025-12-29 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-28 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-12 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-09 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-06 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-12-03 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-27 | Prior Intimation Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-27 | Intimation Of Submission Of Draft Letter Of Offer For The Proposed Rights Issue | View |